NVIDIA details RFD4-Proteina protein design search workflow
NVIDIA says RFD4-Proteina uses reward-guided inference-time search to co-design protein sequences and all-atom structures.
NVIDIA expands healthcare AI push with protein design and radiotherapy
NVIDIA announced healthcare and life sciences collaborations on protein design, scientific agents and adaptive radiotherapy at GTC Berlin on Oct. 21, 2026.
Anthropic says Claude designed binders for scorpion neurotoxins
Anthropic says Claude helped design 211 minibinders against scorpion neurotoxins, with 17 meeting binding criteria in lab tests.
NVIDIA Releases Proteina-Complexa AI Model for Drug Discovery
NVIDIA's new generative AI model designs protein binders with nano- and picomolar binding affinities, validated across 133 targets with pharma partners.
NVIDIA and MMseqs2 Revolutionize Protein Design with GPU Acceleration
NVIDIA's collaboration with MMseqs2 enhances protein sequence alignment using GPU acceleration, promising significant advancements in AI-driven drug discovery and protein design.
NVIDIA Introduces BioNeMo Blueprint to Revolutionize Protein Binder Design
NVIDIA unveils the BioNeMo Blueprint, a new AI-powered approach to accelerate protein binder design in drug discovery, leveraging GPU-accelerated microservices.
NVIDIA: EvolutionaryScale Unveils ESM3 Generative AI Model for Protein Design
EvolutionaryScale launches ESM3, an advanced AI model for protein design, leveraging NVIDIA's H100 GPUs to accelerate biological research.